Dermata Therapeutics Reports Q2 2026 Financial Results and Corporate Update

What Happened
Dermata Therapeutics, Inc. (DRMA) announced and reported its results of operations for the quarter ended June 30, 2026 and provided a corporate update via a press release dated August 11, 2026. The company furnished that press release in an 8-K filing (Item 2.02) and included the release as Exhibit 99.1 to the filing.

Key Details

• Filing date: August 11, 2026 (Form 8-K).
• Reporting period: Quarterly results for the period ended June 30, 2026.
• Disclosure: Press release titled “Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026” furnished as Exhibit 99.1.
• Technical exhibit: Interactive XBRL cover page (Exhibit 104) was included.

Why It Matters
The 8-K signals that Dermata has published its quarterly results and a corporate update—information investors use to assess recent earnings, revenue trends, cash position, and program progress. Retail investors should review the furnished press release (Exhibit 99.1) and related SEC filings for the detailed financial figures and management commentary to understand implications for the company’s outlook and valuation.